Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels
J. Wouter Jukema(Leiden University Medical Center), Kong I. Lie(Leiden University), Johan H. C. Reiber(Erasmus University Rotterdam), Hans Jansen(Leiden University), Aeilko H. Zwinderman(Amsterdam Neuroscience), Feikje M. van Rappard(Leiden University), Ad J. van Boven(Leiden University), Geert J. M. Boerma(Leiden University), Egbert T. Bal(Leiden University), Albert V.G. Bruschke(Leiden University Medical Center)
Cited by 844
Related Papers
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
|Journal of Clinical Epidemiology|2005|3.3k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k
The Athlete’s Heart
|Circulation|2000|1.1k